Open Access
Issue
Published:
14 November 2022
Mechanical insufflation–exsufflation to facilitate ventilator weaning and possible decannulation for patients with encephalopathic conditions
),
Download citation
404
Views
21
Downloads
2
Crossref
1
WoS
0
Scopus
N/A
CSCD
Clinicians are often faced with apparently tracheostomy mechanical ventilation dependent (TMV), patients who are ventilator unweanable due to encephalopathic/upper motor neuron conditions, that hamper return to the community.
A protocol is suggested to wean these patients from mechanical ventilation and criteria offered for possible decannulation.
After excluding patients with severe muscle weakness due to neuromuscular diseases and high level spinal cord disorders, consecutive, apparently unweanable and unresponsive encephalopathic patients were to be weaned by a protocol that first normalized CO2 levels at full ventilatory support settings. Then, supplemental oxygen was discontinued so that ambient air baseline oxyhemoglobin saturation (O2 Sat) could be determined and subsequently be normalized by using mechanical insufflation–exsufflation (MIE), at 60–70 cmH2O pressures, via the tubes every 2 hours, with the tube cuffs inflated. Once ambient air O2 Sat levels remained normal, ambient air spontaneous, unassisted autonomous breathing "sprints" were initiated and continued until O2 Sat decreased below 95% with respiratory distress. Patients spontaneously moving over 300 mL of air into their lungs without pressure support had very good prognoses for rapid ventilator weaning. Patients were not returned to TMV irrespective of tachypnea. After the "sprint", they were rested by using 1–3 hours of full ventilatory support before the next sprint. Sprints lengthened until being fully weaned. After weaning, potential decannulation was evaluated using MIE expiratory flows (MIE-EF) and O2 Sat.
O2 Sat normalized from the initial use of MIE via the tube for 7 of 13 patients then 4 weaned from the initial ambient air sprint. Weaning occurred in 4 days or less for 11 of 13. Despite continuous TMV dependence for 31 days to 15 months before the intervention, 7 weaned patients were successfully decannulated, 6 of the 7 with MIE-EF ≥ 190 L/m. All but 2 remained unresponsive, but 6 were discharged home to their families once decannulated.
Once primary ventilatory pump failure is excluded and lung disease improved to the extent that the ambient air O2 Sat can be normalized by using MIE via invasive airway tubes to clear airway secretions, encephalopathic patients can have sufficient muscle strength to wean from ventilatory support and possibly be decannulated if mechanically augmented cough flows exceed 190 L/m.
menu
Mechanical insufflation–exsufflation to facilitate ventilator weaning and possible decannulation for patients with encephalopathic conditions
),
Abstract
Clinicians are often faced with apparently tracheostomy mechanical ventilation dependent (TMV), patients who are ventilator unweanable due to encephalopathic/upper motor neuron conditions, that hamper return to the community.
A protocol is suggested to wean these patients from mechanical ventilation and criteria offered for possible decannulation.
After excluding patients with severe muscle weakness due to neuromuscular diseases and high level spinal cord disorders, consecutive, apparently unweanable and unresponsive encephalopathic patients were to be weaned by a protocol that first normalized CO2 levels at full ventilatory support settings. Then, supplemental oxygen was discontinued so that ambient air baseline oxyhemoglobin saturation (O2 Sat) could be determined and subsequently be normalized by using mechanical insufflation–exsufflation (MIE), at 60–70 cmH2O pressures, via the tubes every 2 hours, with the tube cuffs inflated. Once ambient air O2 Sat levels remained normal, ambient air spontaneous, unassisted autonomous breathing "sprints" were initiated and continued until O2 Sat decreased below 95% with respiratory distress. Patients spontaneously moving over 300 mL of air into their lungs without pressure support had very good prognoses for rapid ventilator weaning. Patients were not returned to TMV irrespective of tachypnea. After the "sprint", they were rested by using 1–3 hours of full ventilatory support before the next sprint. Sprints lengthened until being fully weaned. After weaning, potential decannulation was evaluated using MIE expiratory flows (MIE-EF) and O2 Sat.
O2 Sat normalized from the initial use of MIE via the tube for 7 of 13 patients then 4 weaned from the initial ambient air sprint. Weaning occurred in 4 days or less for 11 of 13. Despite continuous TMV dependence for 31 days to 15 months before the intervention, 7 weaned patients were successfully decannulated, 6 of the 7 with MIE-EF ≥ 190 L/m. All but 2 remained unresponsive, but 6 were discharged home to their families once decannulated.
Once primary ventilatory pump failure is excluded and lung disease improved to the extent that the ambient air O2 Sat can be normalized by using MIE via invasive airway tubes to clear airway secretions, encephalopathic patients can have sufficient muscle strength to wean from ventilatory support and possibly be decannulated if mechanically augmented cough flows exceed 190 L/m.
References(20)
Bach JR, Sinquee DM, Saporito LR, et al. Efficacy of mechanical insufflation-exsufflation in extubating unweanable subjects with restrictive pulmonary disorders. Respir Care. 2015;60(4): 477-483.
Bach JR, Gonçalves MR, Hamdani I, et al. Extubation of unweanable patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137(5): 1033-1039.
Fishburn MJ, Marino RJ, Ditunno JF. Atelectasis and pneumonia in acute spinal cord injury. Arch Phys Med Rehabil. 1990;71(3): 197-200.
Bach JR. Noninvasive respiratory management of patients with neuromuscular disease. Ann Rehabil Med. 2017;41(4): 519-538.
Bach JR, Burke L, Chiou M. Noninvasive respiratory management of spinal cord injury. Phys Med Rehabil Clin. 2020;31(3): 397-413.
Andersen T, Sandnes A, Brekka AK, et al. Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis. Thorax. 2017;72(3): 221-229.
Bach JR, Saporito LR, Shah HR, et al. Decannulation of patients with severe respiratory muscle insufficiency: efficacy of mechanical insufflation-exsuf-flation. J Rehabil Med. 2014;46(10): 1037-1041.
Bach JR, Upadhyaya N. Association of need for tracheotomy with decreasing mechanical in-exsufflation flows in amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2018;97(4): e20-e22.
Leger P, Jennequin J, Gerard M, et al. Home positive pressure ventilation via nasal mask for patients with neuromusculoskeletal disorders. Eur Respir J Suppl. 1989;7: 640s-644s.
Chiou M, Bach JR, Saporito LR, et al. Quantitation of oxygen-induced hyper-capnia in respiratory pump failure. Revista Portuguesa De Pneumol Engl Ed. 2016;22(5): 262-265.
Westermann EJ, Jans M, Gaytant MA, et al. Pneumothorax as a complication of lung volume recruitment. J Bras Pneumol. 2013;39(3): 382-386.
Bach JR, Alba AS. Noninvasive options for ventilatory support of the traumatic high level quadriplegic patient. Chest. 1990;98(3): 613-619.
Bach JR. New approaches in the rehabilitation of the traumatic high level quadriplegic. Am J Phys Med Rehabil. 1991;70(1): 13-19.
Bach JR, Martinez D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care. 2011;56(6): 744-750.
Bach JR, Giménez GC, Chiou M. Mechanical in-exsufflation-expiratory flows as indication for tracheostomy tube decannulation: case studies. Am J Phys Med Rehabil. 2019;98(3): e18-e20.
Bach JR, Chiou M. Limitations of evidence-based medicine. Revista Portuguesa De Pneumol Engl Ed. 2016;22(1): 4-5.
MacIntyre NR, Cook DJ, Ely EW, et al. Evidence-based guidelines for weaning and discontinuing ventilatory support: a collective task force facilitated by the American College of chest physicians; the American Association for Respiratory care; and the American College of critical care Medicine. Chest. 2001;120(6 suppl l), 375S-95S.
Hansen-Flaschen J. Respiratory care for patients with amyotrophic lateral sclerosis in the US: in need of support. JAMA Neurol. 2021;78(9): 1047-1048.
Publication history
Copyright
Rights and permissions
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
FEEDBACK 
TOP